Alto Neuroscience Statistics
Total Valuation
ANRO has a market cap or net worth of $104.87 million. The enterprise value is -$74.42 million.
Important Dates
The next estimated earnings date is Monday, November 11, 2024, before market open.
| Earnings Date | Nov 11, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ANRO has 26.96 million shares outstanding. The number of shares has increased by 251.86% in one year.
| Shares Outstanding | 26.96M |
| Shares Change (YoY) | +251.86% |
| Shares Change (QoQ) | +52.91% |
| Owned by Insiders (%) | 8.27% |
| Owned by Institutions (%) | 50.22% |
| Float | 19.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.60 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 19.85, with a Debt / Equity ratio of 0.06.
| Current Ratio | 19.85 |
| Quick Ratio | 19.62 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -38.39 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$743,358 |
| Employee Count | 67 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 11.46 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 22.49 |
| Average Volume (20 Days) | 1,526,858 |
Short Selling Information
The latest short interest is 3.06 million, so 11.36% of the outstanding shares have been sold short.
| Short Interest | 3.06M |
| Short Previous Month | 3.67M |
| Short % of Shares Out | 11.36% |
| Short % of Float | 15.79% |
| Short Ratio (days to cover) | 11.82 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -54.21M |
| Pretax Income | n/a |
| Net Income | -49.81M |
| EBITDA | -53.83M |
| EBIT | -54.21M |
| Earnings Per Share (EPS) | -$3.82 |
Full Income StatementBalance Sheet
The company has $193.12 million in cash and $10.06 million in debt, giving a net cash position of $183.06 million or $6.79 per share.
| Cash & Cash Equivalents | 193.12M |
| Total Debt | 10.06M |
| Net Cash | 183.06M |
| Net Cash Per Share | $6.79 |
| Equity (Book Value) | 179.78M |
| Book Value Per Share | 6.67 |
| Working Capital | 185.57M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$41.97 million and capital expenditures -$959,000, giving a free cash flow of -$42.93 million.
| Operating Cash Flow | -41.97M |
| Capital Expenditures | -959,000 |
| Free Cash Flow | -42.93M |
| FCF Per Share | -$1.59 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |